Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: - | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Basic toxicokinetics
Administrative data
- Endpoint:
- basic toxicokinetics in vivo
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- Test procedures cannot be subsumed under a testing guideline, nevertheless are well documented and scientifically acceptable. Justification for Read Across is detailed in the Toxicokinetics summary and in the Category Justification Report attached in section 13
Data source
Referenceopen allclose all
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 973
- Report date:
- 1973
- Reference Type:
- publication
- Title:
- Unnamed
- Year:
- 1 975
Materials and methods
- Objective of study:
- metabolism
- Principles of method if other than guideline:
- The behaviour of three water-soluble fluorescent whitening agents (FWAs - including the test item) was studied in rats using 14C-labelled compounds. The fate of 14C-labeled test substance was followed in the rat. The animals dosed with 5.97 ± 0.33 mg/kg (actual dose) and faeces, urine and expired CO2 were monitored. After 96 hours animals were killed and tissues analyzed.
- GLP compliance:
- no
Test material
Constituent 1
- Radiolabelling:
- yes
- Remarks:
- 14C
Test animals
- Species:
- rat
- Strain:
- other: SIV 50
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Ivanovas, Kisslegg, Germany
- Breeding: under SPF conditions
- Weight at study initiation: approximately 200 g
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Duration and frequency of treatment / exposure:
- Single application.
Doses / concentrations
- Remarks:
- Doses / Concentrations:
6.1 ± 0.1 mg/kg for females and 5.9 ± 0.2 mg/kg for males (mean ± SEM)
- No. of animals per sex per dose / concentration:
- 4
- Control animals:
- no
- Details on study design:
- ANIMALS CONDITION after dosing
- Housing: the animals were kept in all-glass metabolism cages
- Food: ad libitum, commericial food
- Water: ad libitum
- Sacrifice: the animals were killed after 96 hours by decapitation - Details on dosing and sampling:
- SAMPLES collaction
- Samples before sacrifice: urine, faeces and expired CO2
- Time and frequency of sampling: 16 or 24, 40 or 48, 64 or 72 hours after application
- Samples after sacrifice: blood, liver, kidney, brain, muscle and fat
ANALYSIS
- Method type for identification: liquid scintillation counting (Model 3375 Tricarb)
- Limits of detection and quantification: 0.01 ppm
- Radioactivity: the radioactivity in the dry material was determined by combustion
- Faeces: TLC (Thin Layer Chromatography)
- Sample preparation: liqui samples were measured directly. Faeces were lyophilized and ground to a fine powder in a disc mill. CO2: expired CO2 was trapped in ethanolamine solution.
- Tissues: animal tissues and blood were solubilized with a 1:1 mixture of 2-propanol:toluene and the resulting solutions were decolorized with hydrogen peroxide before adding the scintillation cocktail for counting.
Results and discussion
Main ADME results
- Type:
- excretion
- Results:
- More than 90 % of the administered radioactive material was excreted within 48 hours.
Toxicokinetic / pharmacokinetic studies
- Details on absorption:
- The results indicate that there is virtually no absorption from the gut of the test substance.
- Details on distribution in tissues:
- Residues in all tissues investigated were below the limit of quantitative determination which was 0.005-0.01 ppm test item equivalent.
- Details on excretion:
- The faeces proved to be practically the only route of elimination for the applied radioactive material. About 90 % of the applied radioactivity was eliminated in faeces within 24 hours of dosing, indicating, in combination with the short half life times, that no significant amounts of test substance were absorbed from the gastro-intestinal tract.
Radioactivity found in urine was at the limit of detection (0.02 %. of applied dose).
No radioactivity was found in the expired air (< 0.01 %).
No sex differences were observed.
A calculation of the excretion half life using the net rate coefficient of drug elimination (24 hours excretion value) revealed that 50% of the dose had been excreted within 7-13 hours after dosing.
Metabolite characterisation studies
- Metabolites identified:
- not measured
- Details on metabolites:
- The results indicate that there is the test substance is not metabolized by the rats.
Any other information on results incl. tables
The radioactive material present in the faeces of the rats treated with the test substance was not extractable with methanol
Excretion of radioactivity by rats after oral dose
Excretion as a percentage of dose (mean± SEM, n= 4) | ||
Male | Female | |
Faeces |
||
0-24 hours | 76.4 | 89.6 |
24-48 hours | 20.7 | 5.6 |
48-96 hours | 0.4 | < 0.1 |
Subtotal | 97.5 | 95.2 |
Urine |
||
0-96 hours | < 0.1 | < 0.1 |
Expired CO2 |
||
0-48 hours | < 0.01 | < 0.01 |
Cage wash |
< 0.1 | < 0.1 |
Total recovery |
97.5 ± 1.8 | 95.2 ± 1 |
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): no bioaccumulation potential based on study results
The faeces proved to be practically the only route of elimination (half life ranging from 7-13 hours). - Executive summary:
Method
The behaviour of three water-soluble fluorescent whitening agents (FWAs - including the test item) was studied in rats using 14C-labelled compounds. The fate of 14C-labeled test substance was followed in the rat. The animals dosed with 5.97 ± 0.33 mg/kg (actual dose) and faeces, urine and expired CO2 were monitored. After 96 hours animals were killed and tissues analyzed.
Results
Following oral doses of 5 mg/kg to rats rapid and complete excretion of radioactive material was observed with an excretion half life ranging from 7-13 hours. Faeces were practically the only route of excretion indicating, in combination with the short half life times, that no significant amounts of whitener were absorbed from the digestive tract. No radioactive residues were found in blood, liver, kidney, brain, muscle, or fat 96 hours after dosing (limit of quantitative determination 0.005-0.01 ppm FWA equivalents).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
This website uses cookies to ensure you get the best experience on our websites.
Find out more on how we use cookies.